SynthesisJournal of diabetes investigation2022

Dipeptidyl peptidase-4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta-analysis.

Xianling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.